Literature DB >> 24336559

ColonCancerCheck primary care invitation pilot project: patient perceptions.

Jill Tinmouth1, Paul Ritvo, S Elizabeth McGregor, Jigisha Patel, Crissa Guglietti, Cheryl A Levitt, Lawrence F Paszat, Linda Rabeneck.   

Abstract

OBJECTIVE: To describe the perceptions of those who received invitations to the ColonCancerCheck Primary Care Invitation Pilot (the Pilot) about the mailed invitation, colorectal cancer (CRC) screening in general, and their specific screening experiences.
DESIGN: Qualitative study with 6 focus group sessions, each 1.5 hours in length.
SETTING: Hamilton, Ont; Ottawa, Ont; and Thunder Bay, Ont. PARTICIPANTS: Screening-eligible adults, aged 50 years and older, who received a Pilot invitation for CRC screening.
METHODS: The focus groups were conducted by a trained moderator and were audiorecorded and transcribed verbatim. The transcripts were analyzed using grounded-theory techniques facilitated by the use of electronic software. MAIN
FINDINGS: Key themes related to the invitation letter, the role of the family physician, direct mailing of the fecal occult blood testing (FOBT) kit, and alternate CRC screening promotion strategies were identified. Specifically, participants suggested the letter content should use stronger, more powerful language to capture the reader's attention. The importance of the family physician was endorsed, although participants favoured clarification of the physician and program roles in the actual mailed invitation. Participants expressed support for directly mailing FOBT kits to individuals, particularly those with successful previous test completion, and for communication of both negative and positive screening results.
CONCLUSION: This study yielded a number of important findings including strategies to optimize letter content, support for directly mailed FOBT kits, and strategies to report results that might be highly relevant to other health programs where population-based CRC screening is being considered.

Entities:  

Mesh:

Year:  2013        PMID: 24336559      PMCID: PMC3860944     

Source DB:  PubMed          Journal:  Can Fam Physician        ISSN: 0008-350X            Impact factor:   3.275


  26 in total

1.  A randomized trial of direct mailing of fecal occult blood tests to increase colorectal cancer screening.

Authors:  Timothy R Church; Mark W Yeazel; Resa M Jones; Laura K Kochevar; Gavin D Watt; Steven J Mongin; Jill E Cordes; Deborah Engelhard
Journal:  J Natl Cancer Inst       Date:  2004-05-19       Impact factor: 13.506

2.  Media messages about cancer: what do people understand?

Authors:  Kathleen M Mazor; Josephine Calvi; Rebecca Cowan; Mary E Costanza; Paul K J Han; Sarah M Greene; Laura Saccoccio; Erica Cove; Douglas Roblin; Andrew Williams
Journal:  J Health Commun       Date:  2010

3.  Electronic patient messages to promote colorectal cancer screening: a randomized controlled trial.

Authors:  Thomas D Sequist; Alan M Zaslavsky; Graham A Colditz; John Z Ayanian
Journal:  Arch Intern Med       Date:  2010-12-13

4.  A qualitative evaluation of strategies to increase colorectal cancer screening uptake.

Authors:  Jill Tinmouth; Paul Ritvo; S Elizabeth McGregor; Danielle Claus; George Pasut; Ronald E Myers; Crissa Guglietti; Lawrence F Paszat; Robert J Hilsden; Linda Rabeneck
Journal:  Can Fam Physician       Date:  2011-01       Impact factor: 3.275

5.  ColonCancerCheck Primary Care Invitation Pilot project: family physician perceptions.

Authors:  Jill Tinmouth; Paul Ritvo; S Elizabeth McGregor; Criss Guglietti; Josh Green; Danielle Claus; Cheryl Levitt; Lawrence F Paszat; Linda Rabeneck
Journal:  Can Fam Physician       Date:  2012-10       Impact factor: 3.275

6.  Comparing different strategies for colorectal cancer screening in Italy: predictors of patients' participation.

Authors:  Carlo Senore; Paola Armaroli; Marco Silvani; Bruno Andreoni; Luigi Bisanti; Luisa Marai; Guido Castiglione; Grazia Grazzini; Serena Taddei; Stefano Gasperoni; Orietta Giuliani; Giuseppe Malfitana; Anna Marutti; Giovanna Genta; Nereo Segnan
Journal:  Am J Gastroenterol       Date:  2009-10-13       Impact factor: 10.864

7.  Colorectal cancer testing in Canada--2008.

Authors:  Kathryn Wilkins; Margot Shields
Journal:  Health Rep       Date:  2009-09       Impact factor: 4.796

8.  A population-based estimate of the extent of colorectal cancer screening in Ontario.

Authors:  Linda Rabeneck; Lawrence F Paszat
Journal:  Am J Gastroenterol       Date:  2004-06       Impact factor: 10.864

9.  Once-only sigmoidoscopy in colorectal cancer screening: follow-up findings of the Italian Randomized Controlled Trial--SCORE.

Authors:  Nereo Segnan; Paola Armaroli; Luigina Bonelli; Mauro Risio; Stefania Sciallero; Marco Zappa; Bruno Andreoni; Arrigo Arrigoni; Luigi Bisanti; Claudia Casella; Cristiano Crosta; Fabio Falcini; Franco Ferrero; Adriano Giacomin; Orietta Giuliani; Alessandra Santarelli; Carmen Beatriz Visioli; Roberto Zanetti; Wendy S Atkin; Carlo Senore
Journal:  J Natl Cancer Inst       Date:  2011-08-18       Impact factor: 13.506

Review 10.  Effective interventions to facilitate the uptake of breast, cervical and colorectal cancer screening: an implementation guideline.

Authors:  Melissa C Brouwers; Carol De Vito; Lavannya Bahirathan; Angela Carol; June C Carroll; Michelle Cotterchio; Maureen Dobbins; Barbara Lent; Cheryl Levitt; Nancy Lewis; S Elizabeth McGregor; Lawrence Paszat; Carol Rand; Nadine Wathen
Journal:  Implement Sci       Date:  2011-09-29       Impact factor: 7.327

View more
  2 in total

1.  Equity and practice issues in colorectal cancer screening: Mixed-methods study.

Authors:  Sandy Buchman; Linda Rozmovits; Richard H Glazier
Journal:  Can Fam Physician       Date:  2016-04       Impact factor: 3.275

2.  Evaluation of the colorectal cancer screening Programme in the Basque Country (Spain) and its effectiveness based on the Miscan-colon model.

Authors:  I Idigoras; A Arrospide; I Portillo; E Arana-Arri; L Martínez-Indart; J Mar; H J de Koning; R Lastra; M Soto-Gordoa; M van der Meulen; I Lansdorp-Vogelaar
Journal:  BMC Public Health       Date:  2017-08-01       Impact factor: 3.295

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.